Kura Oncology (KURA) Prepaid Assets (2010 - 2026)
Kura Oncology (KURA) reported Prepaid Assets of $32.8 million for Q1 2026, up 89.84% year-over-year from $17.3 million in Q1 2025, and up 1.75% quarter-over-quarter from $32.2 million in Q4 2025.
Kura Oncology (KURA) Prepaid Assets (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 17 years of Prepaid Assets data on file, last reported at $32.8 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $32.8 million, up 89.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.8 million (up 89.84% YoY), and the FY2025 annual result was $32.2 million, up 109.48% from the prior year.
- Prepaid Assets climbed to $32.8 million in Q1 2026 per KURA's latest filing, from $32.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $35.1 million in Q3 2025 and troughed at $7.0 million in Q1 2022.
- A 5-year average of $14.9 million and a median of $9.5 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets decreased 15.0% in 2023, then soared 344.27% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $8.4 million in 2022, then grew by 0.98% to $8.5 million in 2023, then jumped by 80.36% to $15.4 million in 2024, then jumped by 109.48% to $32.2 million in 2025, then rose by 1.75% to $32.8 million in 2026.
- Business Quant data shows KURA's Prepaid Assets at $32.8 million in Q1 2026, $32.2 million in Q4 2025, and $35.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77 Mn |
| Dec 31, 2025 | 32.21 Mn |
| Sep 30, 2025 | 35.06 Mn |
| Jun 30, 2025 | 24.77 Mn |
| Mar 31, 2025 | 17.26 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Sep 30, 2024 | 7.89 Mn |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | 10.71 Mn |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 7.32 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 10.55 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 9.53 Mn |
| Mar 31, 2022 | 6.96 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 5.46 Mn |
| Jun 30, 2021 | 6.14 Mn |